Tag: NTLA-2002

KLKB1 gene editing therapy reduces kallikrein levels in hereditary angioedema

byNhat Hung (Benjamin) Lamand1 others

February 5, 2024

1. In this randomized controlled trial, gene-editing therapy targeting the kallikrein B1 gene (KLKB1) led to a significant reduction in ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Placental abruption during pregnancy is not associated with increased risk of cardiovascular mortality in children
Pfizer’s Talzenna combo significantly delays prostate cancer progression
Bottom-vented bottles may not reduce gastrointestinal discomfort in infants

No Result

View All Result